Corline Biomedical AB | |
Stock Exchange | First North Sweden |
EPS |
SEK0.45 |
Market Cap |
SEK378.6 M |
Shares Outstanding |
15.77 M |
Public Float |
- |
Address |
Lefflersgatan 5 Uppsala UP 754 50 Sweden |
Employees | - |
Website | http://www.corline.se |
Updated | 09/14/2018 |
Corline Biomedical AB engages in the research, development, and commercialization of heparin based solutions. Its products intend to improve kidney transplantation, cell therapies, and applications. It operates under the following trademarks: CHC, Renaparin, Cytoparin, and CHS. |